A Prospective, Comparative, Multicenter, Randomized Study to Compare the Safety and Efficacy of Sirolimus (Rapamune) to Tacrolimus (Advagraf) Associated to Mycophenolate Mofetil (CellCept) Between 12 and 24 Months After Kidney Transplantation.
Phase of Trial: Phase III
Latest Information Update: 29 Jul 2014
At a glance
- Drugs Sirolimus (Primary) ; Tacrolimus
- Indications Renal transplant rejection
- Focus Adverse reactions
- Acronyms EPARGNE
- 18 Jun 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 10 Jan 2013 Planned end date changed from 1 Dec 2013 to 1 Jun 2014 as reported by ClinicalTrials.gov.
- 10 Jan 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.